Special Report: Will the COVID-19 Recovery Be Bumpier than Expected?
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
From - Laboratory Industry Report
LabCorp has received emergency approval from the U.S. Food and Drug Administration for a molecular-based rapid detection test for…
From - Laboratory Industry Report
The California-based molecular laboratory Veracyte has published a new study suggesting its Percepta bronchial genomic test can reduce the rate of…
From - Laboratory Industry Report
A new study in the New England Journal of Medicine has given credence to a molecular assay by California-based Genomic Health as a…